XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 5,592 $ 25,849
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 57,903 58,214
Amortization of deferred financing costs 1,452 2,806
Credit loss expense 81 37
Deferred income tax (benefit) expense (4,770) 1,145
Equity-based employee and director compensation expense 1,134 2,084
Loss (gain) on dispositions and lease terminations, net 6,546 (5,220)
Changes in operating assets and liabilities, net of acquisitions 8,734 (5,926)
Net cash provided by operating activities 76,672 78,989
Cash flows from investing activities:    
Principal payments received on notes receivable 117 162
Proceeds from sale of assets 17,969 4,983
Capital expenditures (19,131) (21,680)
Lease terminations payments to Applegreen, including inventory purchases (25,517)  
Net cash used in investing activities (26,562) (16,535)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 90,919 221,900
Repayments on revolving credit facilities (74,500) (65,537)
Repayments on the Term Loan Facility   (158,980)
Payments of finance lease obligations (2,294) (2,150)
Payments of deferred financing costs (74) (7,106)
Distributions paid on distribution equivalent rights (194) (168)
Income tax distributions paid on preferred membership interests (1,312) (900)
Distributions paid on common units (59,880) (59,777)
Net cash used in financing activities (47,335) (72,718)
Net increase (decrease) in cash and cash equivalents 2,775 (10,264)
Cash and cash equivalents at beginning of period 4,990 16,054
Cash and cash equivalents at end of period $ 7,765 $ 5,790